Physician profile
Angelina Postoev
NPI 1558539155
$8,427.46
in general payments reported to CMS, 2019-2025
14 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,247 · 2020: $2,239 · 2021: $1,071 · 2022: $932 · 2023: $967 · 2024: $397 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,938.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,200.00 | 2019-2020 | |
| Abbvie INC. | $1,837.07 | 2023-2025 | |
| Allergan, INC. | $1,741.56 | 2019-2022 | |
| Novo Nordisk INC | $588.75 | 2020-2022 | |
| Merz North America, INC. | $193.88 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $180.15 | 2019-2022 | |
| Intuitive Surgical, INC. | $153.49 | 2019-2021 | |
| Apollo Endosurgery US INC | $146.71 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Endogastric Solutions, INC | $140.38 | 2019-2020 | |
| Mentor Worldwide LLC | $81.98 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.60 | 2020 | |
| Currax Pharmaceuticals LLC | $42.24 | 2020-2021 | |
| Galderma Laboratories, L.P. | $27.81 | 2020-2022 | |
| Mvp Orthopedics INC | $23.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelina Postoev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.